Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk

Genetics in Medicine

Volumn 20, Issue 2, 2018, Pages 234-239

  Caswell Jin, Jennifer L ^a   Gupta, Tanya ^a   Hall, Evan ^a   Petrovchich, Iva M ^a   Mills, Meredith A ^a   Kingham, Kerry E ^a   Koff, Rachel ^a   Chun, Nicolette M ^a   Levonian, Peter ^a   Lebensohn, Alexandra P ^a   Ford, James M ^a   Kurian, Allison W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hereditary cancer panel; Multiple gene panel testing; Next generation sequencing; Race ethnicity; Variants of unknown significance

Indexed keywords

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CAUCASIAN; CHEK2 GENE; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; GENE NUMBER; GENE SEQUENCE; GENETIC DISORDER; GENETIC VARIABILITY; GENETIC VARIATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONCOGENE; OVARY CANCER; YOUNG ADULT; AGED; ANCESTRY GROUP; DNA SEQUENCE; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HEREDITARY TUMOR SYNDROME; HIGH THROUGHPUT SEQUENCING; PROCEDURES; RISK ASSESSMENT;

TUMOR MARKER;

ADULT; AGED; BIOMARKERS, TUMOR; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; RISK ASSESSMENT; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 85042507179     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2017.96     Document Type: Article

References (25)

1. Churpek JE, Walsh T, Zheng Y, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat. 2015;149:31-39.
2. Couch FJ, Hart SN, Sharma P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 2015;33:304-311.
3. Desmond A, Kurian AW, Gabree M, et al. Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol. 2015;1:943-951.
4. Kurian AW, Hare EE, Mills MA, et al. Clinical evaluation of a multiplegene sequencing panel for hereditary cancer risk assessment. J Clin Oncol. 2014;32:2001-2009.
5. LaDuca H, Stuenkel AJ, Dolinsky JS, et al. Utilization of multigene panels in hereditary cancer predisposition testing: Analysis of more than 2, 000 patients. Genet Med 2014;16:830-837.
6. Maxwell KN, Wubbenhorst B, D'Andrea K, et al. Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genet Med 2015;17:630-638.
7. Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482-490.
8. Ricker C, Culver JO, Lowstuter K, et al. Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. Cancer Genet. 2016;209: 130-137.
9. Susswein LR, Marshall ML, Nusbaum R, et al. Pathogenic and likely pathogenic variant prevalence among the first 10, 000 patients referred for next-generation cancer panel testing. Genet Med 2016;18: 823-832.
10. Thompson ER, Rowley SM, Li N, et al. Panel testing for familial breast cancer: calibrating the tension between research and clinical care. J Clin Oncol 2016;34:1455-1459.
11. Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 2015;121: 25-33.
12. Tung N, Lin NU, Kidd J, et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 2016;34:1460-1468.
13. Daly MB, Pilarski R, Axilbund JE, et al. Genetic/familial high-risk assessment: breast and ovarian, Version 2.2015. J Natl Compr Canc Netw 2016;14:153-162.
14. Tung N, Domchek SM, Stadler Z, et al. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol. 2016;13:581-588.
15. Manrai AK, Funke BH, Rehm HL, et al. Genetic misdiagnoses and the potential for health disparities. N Engl J Med 2016;375:655-665.
16. Spratt DE, Chan T, Waldron L, et al. Racial/ethnic disparities in genomic sequencing. JAMA Oncol. 2016;2:1070-1074.
17. Daly MB, Pilarski R, Axilbund JE, et al. Genetic/familial high-risk assessment: Breast and ovarian, version 2.2015. J Natl Compr Canc Netw 2016;14;153-162.
18. Provenzale D, Gupta S, Ahnen DJ, et al. Genetic/familial high-risk assessment: Colorectal version 1.2016. J Natl Compr Canc Netw 2016;14;1010-1030.
19. Kurian AW, Idos G, Culver J, et al. Safety of multiplex gene testing for inherited cancer risk: interim analysis of a clinical trial. Abstract presented at ASCO Annual Meeting. Chicago, IL, 3-7 June 2016.
20. Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60, 706 humans. Nature 2016;536:285-291.
21. Eggington JM, Bowles KR, Moyes K, et al. A comprehensive laboratorybased program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet 2014;86:229-237.
22. Kurian AW, Li Y, Hamilton AS, et al. Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol; e-pub ahead of print 12 April 2017.
23. Kurian AW, Gong GD, Chun NM, et al. Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol 2008;26: 4752-4758.
24. Brown A & Lopez MH. Mapping the Latino population, by state, county and city. Pew Research Center's Hispanic Trend Projects, 2013. http://www.pewhispanic.org/files/2013/08/latino-populations-in-The-states-counties-And-cities-FINAL.pdf. Accessed 18 April 2017.
25. Pew Research Center. Hispanic population and origin in select U.S. metropolitan areas, 2014. http://www.pewhispanic.org/interactives/hispanic-population-in-select-u-s-metropolitan-Areas/Accessed 18 April 2017.